Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. | Cancer Sci | 2024 | 38475938 | PubTator, text mining | PubMed |
| The significance of Hippo pathway protein expression in oral squamous cell carcinoma. | Front Med (Lausanne) | 2024 | 38444414 | PubTator, text mining | PubMed |
| Inhibition of MST1 ameliorates neuronal apoptosis via GSK3β/β-TrCP/NRF2 pathway in spinal cord injury accompanied by diabetes. | Redox Biol | 2024 | 38430683 | PubTator, text mining | PubMed |
| Activation of the YAP/KLF5 transcriptional cascade in renal tubular cells aggravates kidney injury. | Mol Ther | 2024 | 38414248 | PubTator, text mining | PubMed |
| Genetic associations with ratios between protein levels detect new pQTLs and reveal protein-protein interactions. | Cell Genom | 2024 | 38412862 | PubTator, text mining | PubMed |
| Mst1-Hippo Pathway Triggers Breast Cancer Apoptosis via Inducing Mitochondrial Fragmentation in a Manner Dependent on JNK-Drp1 Axis [Retraction]. | Onco Targets Ther | 2024 | 38375326 | PubTator, text mining | PubMed |
| (S)-10-Hydroxycamptothecin Inhibits EMT-evoked Osteosarcoma Cell Growth and Metastasis by Activating the HIPPO Signaling Pathway. | Comb Chem High Throughput Screen | 2024 | 38369725 | PubTator, text mining | PubMed |
| A unique STK4 mutation truncating only the C-terminal SARAH domain results in a mild clinical phenotype despite severe T cell lymphopenia: Case report. | Front Immunol | 2024 | 38361950 | PubTator, text mining | PubMed |
| Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets. | Cell Commun Signal | 2024 | 38302953 | PubTator, text mining | PubMed |
| DNA demethylation and tri-methylation of H3K4 at the TACSTD2 promoter are complementary players for TROP2 regulation in colorectal cancer cells. | Sci Rep | 2024 | 38302503 | PubTator, text mining | PubMed |
| The diverse influences of relaxin-like peptide family on tumor progression: Potential opportunities and emerging challenges. | Heliyon | 2024 | 38298643 | PubTator, text mining | PubMed |
| Crohn's disease as the intestinal manifestation of pan-lymphatic dysfunction: An exploratory proposal based on basic and clinical data. | World J Gastroenterol | 2024 | 38293325 | PubTator, text mining | PubMed |
| Regulation of AMPK activation by extracellular matrix stiffness in pancreatic cancer. | Genes Dis | 2024 | 38292173 | PubTator, text mining | PubMed |
| The m6A methyltransferase METTL3 drives thyroid cancer progression and lymph node metastasis by targeting LINC00894. | Cancer Cell Int | 2024 | 38291427 | PubTator, text mining | PubMed |
| Molecules in the hippo pathway that regulate Th17 differentiation reveal the severity of ankylosing spondylitis. | Int J Rheum Dis | 2024 | 38287541 | PubTator, text mining | PubMed |
| Mammalian STE20-like kinase 1 inhibits synoviocytes activation in rheumatoid arthritis through mitochondrial dysfunction mediated by SIRT3/mTOR axis. | Inflamm Res | 2024 | 38265688 | PubTator, text mining | PubMed |
| Heat Shock Proteins and Breast Cancer. | Int J Mol Sci | 2024 | 38255948 | PubTator, text mining | PubMed |
| Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection. | Cancers (Basel) | 2024 | 38254762 | PubTator, text mining | PubMed |
| Assessment of wood smoke induced pulmonary toxicity in normal- and chronic bronchitis-like bronchial and alveolar lung mucosa models at air-liquid interface. | Respir Res | 2024 | 38245732 | PubTator, text mining | PubMed |
| Macrophage stimulating protein is a novel transcriptional target of estrogen related receptor gamma in alcohol-intoxicated mice. | Cell Signal | 2024 | 38237793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=11